Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Oncology Research and Treatment|January 25, 2017
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR MutationsSatoshi Igawa, Shiichiro Ryuge, Masaaki Ichinoe, et al.Lung Cancer (Amsterdam, Netherlands)|June 23, 2009
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancerKyoichi Kaira, Tateaki Naito, Toshiaki Takahashi, et al.Oncology Letters|April 26, 2014
Circulating tumor cells as a prognostic factor in patients with small cell lung cancerSatoshi Igawa, Keigo Gohda, Tomoya Fukui, et al.Investigational New Drugs|March 12, 2020
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitorsTaihei Ono, Satoshi Igawa, Shintaro Kurahayashi, et al.Cancer Management and Research|June 20, 2019
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational studySatoshi Igawa, Taihei Ono, Masashi Kasajima, et al.Thoracic Cancer|March 2, 2019
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational studyTaihei Ono, Satoshi Igawa, Takahiro Ozawa, et al.Oncology|February 22, 2017
Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung CancerSatoshi Igawa, Yuichi Sato, Shinichiro Ryuge, et al.Pathology International|February 13, 2018
Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinomaToshihide Matsumoto, Ryo Nagashio, Shinichiro Ryuge, et al.Lung Cancer (Amsterdam, Netherlands)|June 17, 2020
Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer RegistrySatoshi Igawa, Katsuhiko Naoki, Yasushi Shintani, et al.Cancer Management and Research|December 13, 2018
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancerMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.Pageof 11